Why the study?
The gut microbiome influences cardiovascular disease pathophysiology, but clinical translation and standardized microbiome-based therapies remain challenging.
Design
Review of gut microbiome influence on cardiovascular health
Key result
The gut microbiome significantly influences cardiovascular health through microbial metabolites like TMAO and SCFAs, highlighting the potential of microbiome-targeted therapies for cardiovascular disease.
Authors
Loading...
Does not yet support microbiome-targeted therapies in routine care; leaves open their efficacy pending randomized trials.
The gut microbiome and its metabolites significantly influence cardiovascular disease pathophysiology, presenting a potential target for future customized microbiome-based therapies.
Sanat Mahendra Dhoke (2025) conducted a review in Cardiovascular disease. Microbiome-targeted therapies was evaluated. The gut microbiome significantly influences cardiovascular health through microbial metabolites like TMAO and SCFAs, highlighting the potential of microbiome-targeted therapies for cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: